Exercise Therapy for PAD Using Mobile Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorVA Office of Research and Development

About this trial

Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans have limited access to supervised exercise therapy, a facility-based program proven to improve walking ability in PAD, which is poorly attended due to the inconvenience and cost of attending a 12-week program with multiple weekly sessions. This CDA-2 application will investigate the feasibility of home-based exercise therapy (HBET) delivered using mobile health (mHealth) technologies in Veterans with symptomatic PAD. We will partner with the MOVE! program to deliver HBET through group behavioral coaching and a novel wearable activity monitor in a newly proposed program called Smart MOVE!. There is a clear need to provide effective and convenient alternatives to supervised exercise for Veterans with PAD. This study will provide evidence to proceed with Smart MOVE!, a much-needed patient-centered rehabilitation program for Veterans with PAD.

Eligibility criteria

Qualifiers

Age >40 years

Eligible Veteran status

Clinically stable intermittent claudication ( 2 months of Rutherford Class II symptoms, no evidence of chronic limb-threatening ischemia)

Established PAD diagnosis (abnormal ankle-brachial index or evidence of PAD on prior certified vascular laboratory or radiology imaging)

Disqualifiers

Above or below knee amputation

critical limb ischemia (rest pain or tissue loss including ulceration or gangrene)

inability to walk without a walker

wheelchair confinement

Trial design

Treatments tested in this trial

  • Smart MOVE!
  • General walking advice
  • Performance evaluation

Treatment groups

75 Participants
are divided into 3 treatment groups

Sponsors and collaborators